evertex fabrinology limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 155.97 million compared to TWD 95.28 million a year ago. Revenue was TWD 243.55 million compared to TWD 158.46 million a year ago. Net income was TWD 12.75 million compared to TWD 9.49 million a year ago. Basic earnings per share from continuing operations was TWD 0.15 compared to TWD 0.11 a year ago. Diluted earnings per share from continuing operations was TWD 0.15 compared to TWD 0.11 a year ago. For the nine months, sales was TWD 422.6 million compared to TWD 263.16 million a year ago. Revenue was TWD 679.78 million compared to TWD 452.33 million a year ago. Net income was TWD 48.68 million compared to TWD 17.51 million a year ago. Basic earnings per share from continuing operations was TWD 0.57 compared to TWD 0.2 a year ago. Diluted earnings per share from continuing operations was TWD 0.57 compared to TWD 0.2 a year ago.